Jun
15
2018

UK firm Nightstar bags FDA fast-track status for gene therapy

PMLiVE

The RMAT (regenerative medicine advanced therapy) status has been given to NSR-REP1, the London-based biotech’s therapeutic for choroideremia, a rare, degenerative retinal disorder that mainly affects males and causes blindness. Last month, FDA Commissioner Scott Gottlieb told the Alliance for Regenerative Medicine in the US that the RMAT designation is a key part of its plans to help bring forward cell and gene therapies.

Jun
07
2018

New Foundation Will Increase Awareness About Cell and Gene Therapy, but Caution Is Recommended

Alpha-1 Foundation

The Alliance for Regenerative Medicine (ARM) announced the launch of the ARM Foundation for Cell and Gene Medicine, which will be dedicated to increasing public awareness and understanding of the clinical and societal benefits of cell and gene medicine — including gene therapy, gene editing, cell therapy, tissue-engineering, and organ regeneration — and supporting its development through education and research projects.

Jun
07
2018

Stem Cell & Regenerative Medicine News: Cool Pubs, People, ARM, & More

The Niche

The Alliance for Regenerative Medicine (ARM) website has a new look that is worth checking out. ARM is pushing on PR too with a new foundation to “Promote Understanding and Acceptance of Potentially Curative Cell and Gene Therapies.”

Jun
06
2018

BIO Notebook Day 3: ARM Launches Foundation To Educate Public About Gene And Cell Therapies

Pink Sheet Pharma Intelligence

Alliance for Regenerative Medicine initiative seeks to explain gene and cell therapy to the general public.

Jun
06
2018

Alliance for Regenerative Medicine Launches Foundation to Promote Understanding of Cell and Gene Therapies

Rare Daily by Global Genes

The Alliance for Regenerative Medicine has launched the ARM Foundation for Cell and Gene Medicine to educate and engage the public on issues that affect the advancement and acceptance of cell and gene medicines as treatment options. The foundation is in part a response to growing concerns about the lack of accessible information to the public about gene therapy. A recent study of public perceptions found that more than half of the respondents said their top concern was not receiving appropriate information.

Jun
06
2018

ARM Foundation for Cell and Gene Medicine Launched

BioCentury

The Alliance for Regenerative Medicine (ARM) launched an independent, non-profit foundation dedicated to researching, creating and disseminating information about gene and cell therapies. The ARM Foundation for Cell and Gene Medicine will produce educational materials explaining regenerative technologies and produce briefings for journalists, payers and policymakers. It also plans to research policy options for supporting the industrialization of gene and cell therapies.

May
22
2018

Politico Influence

Politico

Members of the Alliance for Regenerative Medicine are in town, too, talking with lawmakers about gene therapy, cell therapy and tissue engineering. They’re meeting with dozens of congressional offices.

May
22
2018

Help Coming on Gene Therapy Development

Politico Pro - Subscription Only

The FDA will soon release a series of guidance documents that it hopes will speed development of the already rapidly growing world of gene therapies, according to Commissioner Scott Gottlieb.